Zika vaccine shows promise in early human trial A DNA-based Zika vaccine from Inovio Pharmaceuticals Inc and South Korea’s GeneOne Life Science Inc induced anti-Zika immune responses in an early stage human trial, U.S. researchers reported on Wednesday. Unlike conventional vaccines, which often use inactivated or killed versions of a […]
